Global Market for Nanocellulose to 2020: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy and Forecast Research Report 2020
Albany, NY (PRWEB) April 02, 2014 -- Over the last few years, the conversion of renewable lignocellulosic biomass and natural biopolymers into chemicals, liquid fuels and feed supplements has received increasing attention. The exploitation of nanostructured cellulose, in the form of nanocrystalline cellulose (NCC), micro/nanofibrillar cellulose (MFC/NFC) and bacterial cellulose (BC) has mainly been motivated by the sustainability trend, ever-increasing prices of petroleum and the high-energy intensity in production of chemicals and synthetic polymers. This growing interest is related to their unsurpassed quintessential physical and chemical properties.
Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/the-global-market-for-nanocellulose-to-2020
Today there is a substantial amount of research on these materials, and commercial development is now underway with some very promising applications. With appropriate conversion and extraction technologies as well as modification and characterization, nanocellulose can be integrated into bio-based products. Their use in novel materials and various applications has substantial environmental and economic benefits. Nanocellulose can be produced from several raw materials and applying various pre-treatments, which yield tailor-made nanofibrils with specific morphology and surface chemistry. The material has great potential in applications such as strength enhancers in paper, as additives, in emulsions, as oxygen barriers for food packaging and in biomedical devices.
Nanocellulose is also being developed for use in novel applications ranging from scaffolds in tissue engineering, artificial skin and cartilage, wound healing and vessel substitutes to biodegradable food packaging. Applications in polymer reinforcement and anti-microbial films will be hitting the market soon. FP Innovations estimates the market to be worth $250 million in North America by 2020.
Browse Full Report With TOC: http://www.marketresearchreports.biz/sample/sample/193016
Table of Content
EXECUTIVE SUMMARY
A novel class of renewable and sustainable nanomaterials.
INTRODUCTION
Nanocellulose properties, advantages and applications.
APPLICATIONS
Applications of NanoFibrillar Cellulose (NFC), NanoCrystalline Cellulose (NCC) and Bacterial Cellulose (BC).
PRODUCTION METHODS
Nanocellulose production techniques.
REGULATIONS & STANDARDS
Initiatives and studies in nanocellulose standards, toxicity and regulation.
COMMERCIALIZATION
To Get Download Full Report with TOC: http://www.marketresearchreports.biz/analysis/193016.
PRODUCTION VOLUMES
Facilities, producers, production capacities, products and prices.
PATENTS AND PUBLICATIONS
Research papers and patent publications on nanocellulose from 1997-2013.
MARKET SUPPLY CHAIN
Overview of the nanocellulose supply chain including producers, application developers and OEMs.
COMPOSITES
Nanocellulose the composites market, including technology roadmap, applications, market penetration estimates and companies.
PAPER & PULP
Nanocellulose the paper & pulp market, including technology roadmap, applications, market penetration estimates and companies.
BIOMEDICAL
Nanocellulose the biomedical market, including technology roadmap, applications, market penetration estimates and companies.
COATINGS & FILMS
Nanocellulose the coatings & films market, including technology roadmap, applications, market penetration estimates and companies.
RHEOLOGY MODIFIERS
Nanocellulose the rheology modifiers market, including technology roadmap, applications, market penetration estimates and companies.
OTHER APPLICATIONS
Graphene in the sensors, aerogels, oil, filtration and electronics markets.
COMPANIES
Producers, application developers and OEMs.
RESEARCH CENTRES
Latest Report:
Gastric Cancer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019 : http://www.marketresearchreports.biz/analysis-details/gastric-cancer-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Gastric cancer refers to the cancer arising from lining of stomach. It may lead to uncontrolled growth of malignant cells that originate in stomach tissue and forms a tumor in any part of the stomach. Mainly there are five types of gastric cancer namely adenocarcinoma, squamous cell cancer, lymphoma, gastrointestinal stromal tumors, neuroendocrine tumors. From all these types, adenocarcinoma types of cancer originates from the innermost lining of stomach and accounts for more than 90% of all gastric tumors. Dysphagia, frequent burping, heartburn, stomachache are some of the early stomach cancer symptoms. The drugs of gastric cancers works on extracellular and intracellular domain of HER2 receptor of stomach and continuously suppress the tumor proliferation that lead to cell stasis and death.
According to World Health Organization, approximately 800,000 cancer related deaths are caused by gastric cancer every year and American Cancer Society estimated that in 2013 approximately 21,600 cases of gastric cancer will be diagnosed. This increasing incidences of gastric cancer drives the market of gastric cancer drugs. In addition, introduction of new therapies like Taxotere, Xeloda and Herceptin are also expected to propel the demand for gastric cancer drugs. However, less number of commercially available drugs for the treatment of gastric cancer may hinder the market growth.
The global Gastric Cancer Drugmarket is categorized based on the following:
By Class of Drugs
Doxorubicin Hydrochloride
Fluorouracil
Trastuzumab
Mitomycin C
Docetaxel
Imatinib
Sunitinib
Geographically, China and Japan dominate the global gastric cancer drug market due to large patient base and rise in treatment seeking population in these regions.Also, with the rise in geriatric population the number of people diagnosed with gastric cancer also increases which ultimately impacts the growth of gastric cancer drugs in these markets. The market of gastric cancer drug in North America and Europeholds a strong growth as the key players are domiciled in these regions. With the rise in uptake of gastric cancer drugs namely is Herceptin, Erbitux and Afitnitor also accentuates the growth of these drugs in the North American and European market.However, the total number of newly diagnosed patients are five times greater in China and Japan than the United States, making Japanese and Chinese market commercially attractive for developers.
Sample Request : http://www.marketresearchreports.biz/sample/toc/192741
Botanical And Plant Derived Drugs Market - Global Industry Analysis, Size, Share, Growth, Trend And Forecast 2013 – 2019: http://www.marketresearchreports.biz/analysis-details/botanical-and-plant-derived-drugs-market-global-industry-analysis-size-share-growth-trend-and-forecast-2013-2019
Botanical drugs are drugs develop through botanical drug and research pathway, whereas plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. These botanical products are intended for use in the mitigation, cure, diagnosis and treatment or prevention of diseases in humans.
The global market for botanical and plant derived drugs is witnessing a significant growth over recent years due to rising usage of these drugs in different parts of the world. Increased focus of research institutes and clinical trial studies, price reduction and improved technological and sociological development are major driving factors for the growth of this market. However, low acceptance of these drugs for the treatment of lethal diseases is a major restraint for the market. On the other hand, rising number of FDA approved botanical drugs and their application is a key opportunity for the market. Some of the major classes of botanical and plant derived drugs are Tarpenes and Steroids, Glycosides, Ergot Alkaloids, Morphine Alkaloids and Vinca Alkaloids.
Global market of botanical and plant derived drugs market is primarily divided into two segments: based on geography and based on therapeutic applications. The U.K., Germany and France are major countries of the European Region. On the basis of therapeutic application, the market is segmented into hormone related disease therapy, infectious diseases, pain and central nervous system disorders, cardiovascular and metabolic diseases, respiratory and oncology diseases treatment. Some of the major players operating in the market are Abott Laboratories, Bayer Healthcare, Bionova, Bristol Myers and Curapharm.
Sample Request : http://www.marketresearchreports.biz/sample/toc/192763
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales(at)marketresearchreports(dot)biz
Gunakesh Parmar, Market Research Reports, http://www.marketresearchreports.biz/, +1 (518) 618-1030, [email protected]
Share this article